Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
---|
09/10/2008 | EP1965805A1 Urea derivatives useful as calcium receptor modulators |
09/10/2008 | EP1965644A1 Novel herbicides |
09/10/2008 | EP1965642A2 Pyrazolyl carboxamides |
09/10/2008 | EP1833799B1 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT-2a SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO |
09/10/2008 | CN101263121A Histone deacetylase inhibitors |
09/10/2008 | CN101263120A 4,5-dihydro-1h-pyrazole derivatives, their preparation and use as medicaments |
09/10/2008 | CN101260081A Preparation method for N-arylazoles compounds |
09/09/2008 | US7423159 Agent for preventing or treating neuropathy |
09/09/2008 | US7423140 An acceptor fluorophore efficiently absorbs energy emission of a linked donor xanthene fluorophore labelling a oligonucleotide primer, reagent for sequencing nucleic acids, DNA sequencing |
09/09/2008 | CA2211646C Substituted phenyl compounds as endothelin antagonists |
09/04/2008 | WO2008104077A1 Small molecule inhibitors of protein arginine methyltransferases (prmts) |
09/04/2008 | US20080214814 Capable of maintaining stability at high temperatures, high pH, under acidic and highly oxidative conditions in the presence of a transition metal; converting methane to methanol; neutralizing nuclear waste treatment; preventing degradation of optical components; metal extraction |
09/04/2008 | US20080214642 Phenyl substituted compounds; herbicidal and fungicidal activity |
09/04/2008 | US20080214641 Chemical compounds 572 |
09/04/2008 | US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist |
09/04/2008 | US20080214635 Modulation of pathogenicity |
09/04/2008 | US20080214559 Compounds with a combination of cannabinoid cb1 antagonism and serotonin reuptake inhibition |
09/04/2008 | US20080214545 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-pyrazol-1-yl}-N-(2-pyrrolidin-1-ylethyl)benzamide; antiproliferatives; angiogenesis inhibitors |
09/04/2008 | US20080214532 Carboxanilides as Microbiocides |
09/04/2008 | US20080214524 e.g. N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; opioid receptor inhibitor; analgesic, antiinflammatory agent; inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity |
09/03/2008 | EP1963276A1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation |
09/03/2008 | EP1963275A2 P2x7 receptor antagonists and uses thereof |
09/03/2008 | EP1963274A1 Benzoylpyrazole compounds and herbicides containing them |
09/03/2008 | EP1963262A2 N-hydroxyamide derivatives possessing antibacterial activity |
09/03/2008 | EP1704143B1 Malononitrile compound as pesticides |
09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
09/02/2008 | US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
09/02/2008 | US7420062 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
09/02/2008 | US7420001 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
08/28/2008 | WO2008102678A1 Fluorine-containing pyrazolecarbonitrile derivative and method for producing the same, and fluorine-containing pyrazolecarboxylic acid derivative obtained by using the fluorine-containing pyrazolecarbonitrile derivative and method for producing the same |
08/28/2008 | WO2008102367A1 Process for preparation of pyrazole derivatives |
08/28/2008 | WO2008101976A1 Fungicide n-(3-phenylpropyl)carboxamide derivatives |
08/28/2008 | WO2008101860A1 Novel process for the preparation of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-n-(piperidin-1-yl)pyrazole-3-carboxamide |
08/28/2008 | US20080207853 Coordination polymerization catalyst |
08/28/2008 | US20080207725 Skin disorders; antiinflamamtory agenst; antiallergens |
08/28/2008 | US20080207721 Chemical compounds |
08/28/2008 | US20080207701 Opioid receptor antagonists |
08/28/2008 | US20080207637 Controlling triglyceride concentration; central nervous system disorders; psychological disorders; eating disordes; drug abuse; anticancer agents |
08/28/2008 | US20080207636 Using a benzmide compound; antidiabetic agents; obesity |
08/27/2008 | EP1961416A1 Medical use of inhibitors of glutaminyl and glutamate cyclases |
08/27/2008 | EP1960379A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides |
08/27/2008 | EP1960367A2 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors |
08/27/2008 | EP1960360A1 Azetidine derivatives as glyt1 inhibitors |
08/27/2008 | EP1960355A1 3-amino-1-arylpropyl indoles and aza-substituted indoles |
08/27/2008 | EP1708996B1 Fused heteroyral derivatives for use as p38 kinase inhibitors |
08/27/2008 | CN101253155A 11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1 |
08/27/2008 | CN101250158A Preparation method of fipronil |
08/26/2008 | US7417152 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring |
08/26/2008 | US7417151 Boron-based organic cations and related methods |
08/26/2008 | US7417063 of the coagulation cascade or contact activation system: thrombin, factor Xa, factor XIa, factor IXa, factor VIIa or plasma kallikrein; e.g. -(6-carbamimidoyl-1H-indol-3-ylmethyl)-4-methoxy-biphenyl-2-carboxylic acid; anticoagulant, antiinflammatory agent |
08/26/2008 | US7417046 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
08/26/2008 | US7416824 Organic photoconductive material electrophotographic photoreceptor and image forming apparatus using the same |
08/26/2008 | CA2532743C Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols |
08/21/2008 | WO2008101247A2 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity |
08/21/2008 | WO2008099794A1 Fused ring compounds as partial agonists of ppar-gamma |
08/21/2008 | WO2008099145A1 Pyrazole derivatives as 11-beta-hsd1 inhibitors |
08/21/2008 | WO2008099139A1 1,5-diaryl-pyrazoles as cannabinoid receptor neutral antagonists useful as therapeutic agents |
08/21/2008 | WO2008099076A2 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof |
08/21/2008 | WO2008098798A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents |
08/21/2008 | WO2008024978A3 Tetrahydroindolone and tetrahydroindazolone derivatives |
08/21/2008 | US20080200694 Process for Making Phenoxy Benzamide Compounds |
08/21/2008 | US20080200693 Derivatives of Aryl (or Heteroaryl) Azolylcarbinols (in Particular Cizolirtin Citrate) for the Treatment of Opioid Addiction |
08/21/2008 | US20080200527 obesity, metabolic syndrome, Type II diabetes, cardiovascular disease, osteoarthritis, cancers; mental disorders; sexual and/or reproductive dysfunctions, epilepsy; 5-(4-Chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid [3-(1H-tetrazol-5-yl)-propyl]-amide |
08/21/2008 | US20080200519 5-Amino-1-(4-fluorophenyl)-N-[6-fluoro-1,2,3,4-tetrahydro-2-hydroxy-5-methoxy-4,4-dimethyl-2-(trifluoromethyl)naphthalene-1-yl]-1H-pyrazole-4-carboxamide; selectivity to glucocorticoid receptor; fewer side effect; inhibit secretion of cytokine IL-8 into monocyte cell line THP-1 triggered by lipopolysacch |
08/21/2008 | US20080200509 Utilizing such as 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide against cancer growth |
08/21/2008 | US20080200501 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; |
08/21/2008 | US20080200478 1,7-Bis-(2,6,6-trimethylcyclohex-1-en-1-yl)-1 (E)-heptadiene-3,5-dione, analogs and derivatives thereof for treating cancer; potent inhibitory effect on the proliferation of human promyelocyte leukemia HL-60 cells |
08/21/2008 | US20080200455 1-Aryl- or 1-Alkylsulfonyl-Heterocyclylbenzazoles As 5-Hydroxytryptamine-6 Ligands |
08/21/2008 | US20080200338 Heteroaroyl-Substituted Serineamides |
08/21/2008 | US20080200336 Substituted 3-hydroxy-4-aryl-5-oxopyrazoline herbicides, and safeners such as N-[4-(2-methoxybenzoylsulfamoyl)phenyl]amides; cereal, maize and sorghum crops |
08/21/2008 | CA2677736A1 Fused ring compounds as partial agonists of ppar-gamma |
08/21/2008 | CA2676154A1 Pyrazole derivatives as 11-beta-hsd1 inhibitors |
08/21/2008 | CA2674087A1 6' substituted compounds having 5-ht6 receptor affinity |
08/20/2008 | EP1958939A2 Pyrazole-amine compounds for the treatment of neurodegenerative disorders |
08/20/2008 | EP1958934A1 Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents |
08/20/2008 | EP1957464A1 INDAZOLE DERIVATIVES THAT INHIBIT TRPVl RECEPTOR |
08/20/2008 | EP1957463A1 Method for producing 5-fluoro-1,3-dialkyl-1h-pyrazol-4-carboxylic acid chlorides |
08/20/2008 | EP1957461A1 Bisamide inhibitors of hedgehog signaling |
08/20/2008 | EP1956909A1 Microbiocides |
08/20/2008 | EP1249233B1 Npyy5 antagonists |
08/20/2008 | CN100412063C Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same |
08/19/2008 | US7414132 prophylaxis and treatment of obesity; secondary amines such as 6-{4-[(3-Methyl-butylamino)-methyl]-phenoxy}-nicotinimidic acid ethyl ester |
08/19/2008 | US7414056 Cytokine inflammatory response suppressors; mitogen activated protein 38 kinases |
08/19/2008 | US7414040 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia |
08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
08/14/2008 | WO2008096151A1 Pharmaceutical compositions of cb1 modulators |
08/14/2008 | WO2008095689A1 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands |
08/14/2008 | WO2008069069A8 Amide compound and salt thereof, and biofilm formation inhibitor or biofilm remover using the same |
08/14/2008 | WO2008019292A3 Compositions and methods for potentiating antibiotic activity |
08/14/2008 | US20080194836 crystalline form of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluorophenyl)urea; 5-HT2A serotonin receptor modulators; condensation of 3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenylamine and 2,4-Difluorophenylisocyanate |
08/14/2008 | US20080194835 higher total yield and increased purity; no Grignard reagent; 3',4'-dichloro-5-fluorobiphenyl-2-amine from N-(2-bromo-4-fluorophenyl)acetamide and 2-methylbutyn-2-ol/3-/ and 3,4-dichlorothiophene-1,1-dioxide; claimed anilide intermediates; for carboxamide fungicides |
08/14/2008 | US20080194816 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound |
08/14/2008 | US20080194650 Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents |
08/14/2008 | US20080194640 Optically Active Tetrahydronaphthalene Derivative |
08/14/2008 | US20080194607 Modulation of pathogenicity |
08/14/2008 | US20080194588 Modulation of pathogcnicity |
08/14/2008 | US20080194582 3,5-Diphenyl-4,5-dihydro-1H-dipyrazole derivatives such as {2-[1-acetyl-3-(2,5-difluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-5-yl]ethyl}(dimethyl)silanol that are useful for treating cancer |
08/14/2008 | US20080194557 methods of treating, managing and preventing pain, inflammation, cancer, and ocular diseases and disorders, and to compounds and pharmaceutical compositions useful in such methods |